| Literature DB >> 24736403 |
Clara Steichen1, Eléanor Luce1, Jérôme Maluenda1, Lucie Tosca1, Inmaculada Moreno-Gimeno1, Christophe Desterke1, Noushin Dianat1, Sylvie Goulinet-Mainot1, Sarah Awan-Toor1, Deborah Burks1, Joëlle Marie1, Anne Weber1, Gérard Tachdjian1, Judith Melki1, Anne Dubart-Kupperschmitt2.
Abstract
The use of synthetic messenger RNAs to generate human induced pluripotent stem cells (iPSCs) is particularly appealing for potential regenerative medicine applications, because it overcomes the common drawbacks of DNA-based or virus-based reprogramming strategies, including transgene integration in particular. We compared the genomic integrity of mRNA-derived iPSCs with that of retrovirus-derived iPSCs generated in strictly comparable conditions, by single-nucleotide polymorphism (SNP) and copy number variation (CNV) analyses. We showed that mRNA-derived iPSCs do not differ significantly from the parental fibroblasts in SNP analysis, whereas retrovirus-derived iPSCs do. We found that the number of CNVs seemed independent of the reprogramming method, instead appearing to be clone-dependent. Furthermore, differentiation studies indicated that mRNA-derived iPSCs differentiated efficiently into hepatoblasts and that these cells did not load additional CNVs during differentiation. The integration-free hepatoblasts that were generated constitute a new tool for the study of diseased hepatocytes derived from patients' iPSCs and their use in the context of stem cell-derived hepatocyte transplantation. Our findings also highlight the need to conduct careful studies on genome integrity for the selection of iPSC lines before using them for further applications. ©AlphaMed Press.Entities:
Keywords: Genome integrity; Hepatic differentiation; SNP/CNV analysis; iPSCs; mRNA reprogramming
Mesh:
Substances:
Year: 2014 PMID: 24736403 PMCID: PMC4039453 DOI: 10.5966/sctm.2013-0158
Source DB: PubMed Journal: Stem Cells Transl Med ISSN: 2157-6564 Impact factor: 6.940